市販薬、販売規制強化へ　２０歳未満は複数購入禁止―厚労省

　若者を中心に広がる市販薬のオーバードーズ（過剰摂取）を巡り、厚生労働省は３０日、乱用の恐れがあるせき止めや風邪薬などの販売規制を強化する方針案をまとめた。２０歳未満は大容量の製品や複数個での販売を禁止し、小容量の製品１個の販売とする。対面または映像と音声によるオンライン購入を原則とし、薬剤師などが氏名や年齢などを確認する。
　同日の検討会で示された。市販薬には違法薬物に似た成分が含まれる製品もあり、大量服用を続けると依存症になる恐れがある。厚労省は１２月にも検討会を開き、取りまとめを行う。（2023/11/30-20:09）

Japan's health ministry has presented a draft plan to strengthen regulations on sales of over-the-counter drugs for cough and cold in response to the spread of overdoses mainly among young people.
   The draft, presented at a meeting Thursday, calls for banning retailers from selling cough and cold remedies that may be abused to people under 20 in large volume or selling more than one product to such people at one time.
   Under the plan, the sale of such drugs would be limited to one product and in small volume each time if the buyer is under 20.
   Such drugs would be made available for purchase to people under 20 only through face-to-face sales at stores or online platforms with video and audio functions in principle. Pharmacists would check the names and ages of the buyers.
   Some OTC drugs contain ingredients similar to those of illegal drugs and therefore may cause addiction if taken in large doses.